What does Pharmacie CANIVET do?

Pharmacie CANIVET is a pharmacy in Soignies. Private Limited, started on 27 February 1991, 1 establishment.

What is the address of Pharmacie CANIVET?

The registered office of Pharmacie CANIVET is located at Place de Naast 27, 7062 Soignies.

Is Pharmacie CANIVET still active?

Yes. According to the CBE (30 October 2026) Pharmacie CANIVET is active, legal situation “Normale toestand”, started on 27 February 1991.

Is Pharmacie CANIVET registered on Peppol?

Yes, Pharmacie CANIVET is registered on the Peppol network with ID 0208:0443306331.

What is the enterprise number of Pharmacie CANIVET?

The enterprise number of Pharmacie CANIVET is BE0443306331.

When was Pharmacie CANIVET founded?

Pharmacie CANIVET was founded on 27 February 1991.

Who are the directors of Pharmacie CANIVET?

According to the 2025 annual accounts, the directors of Pharmacie CANIVET are: Alphar Naast.

Is Pharmacie CANIVET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmacie CANIVET make in 2025?

Pharmacie CANIVET posted a profit after taxes of € 73,901 in financial year 2025.

What is the revenue of Pharmacie CANIVET?

As a small company, Pharmacie CANIVET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 329,744.

How much does an employee at Pharmacie CANIVET earn?

The average wage cost per full-time employee at Pharmacie CANIVET was € 65,200 in 2025: staff costs of € 208,543 for 3.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie CANIVET have?

According to the 2025 annual accounts, Pharmacie CANIVET has 3.2 full-time equivalents (FTE).

Pharmacie CANIVET (Private Limited) - Soignies

Dossier Pharmacie CANIVET, printed on 30 October 2026 from databakkes.be/en/0443306331/pharmacie-canivet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie CANIVET from Soignies, company number BE0443306331, closed financial year 2025 with a result of € 73,901 after tax. For that financial year Pharmacie CANIVET recorded a gross margin of € 329,744 and equity of € 129,918. Compared with financial year 2024, the result moved from € 113,421 to € 73,901. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What it is worth Healthy

€ 129,918

▼ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 73,901

▼ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 81,535

▼ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

3.2

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 208,543

▲ 6% vs 2024

€ 65,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 784

▼ 74% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 179,023

▼ 21% vs 2024

€ 51,245 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 215,406

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,846

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 378,098 Gross margin 2022: € 378,098 First fiscal year in the series	€ 345,642 Gross margin 2023: € 345,642 ▼ 9% vs 2022 (€ 378,098) Unfavourable step	€ 372,512 Gross margin 2024: € 372,512 ▲ 8% vs 2023 (€ 345,642) Favourable step	€ 329,744 Gross margin 2025: € 329,744 ▼ 11% vs 2024 (€ 372,512) Unfavourable step	▼ 11%
Profit after taxes	€ 146,196 Profit after taxes 2022: € 146,196 First fiscal year in the series	€ 102,990 Profit after taxes 2023: € 102,990 ▼ 30% vs 2022 (€ 146,196) Unfavourable step	€ 113,421 Profit after taxes 2024: € 113,421 ▲ 10% vs 2023 (€ 102,990) Favourable step	€ 73,901 Profit after taxes 2025: € 73,901 ▼ 35% vs 2024 (€ 113,421) Unfavourable step	▼ 35%
Equity	€ 149,606 Equity 2022: € 149,606 First fiscal year in the series	€ 152,596 Equity 2023: € 152,596 ▲ 2% vs 2022 (€ 149,606) Favourable step	€ 156,017 Equity 2024: € 156,017 ▲ 2% vs 2023 (€ 152,596) Favourable step	€ 129,918 Equity 2025: € 129,918 ▼ 17% vs 2024 (€ 156,017) Unfavourable step	▼ 17%
Total debts	€ 505,184 Total debts 2022: € 505,184 First fiscal year in the series	€ 615,807 Total debts 2023: € 615,807 ▲ 22% vs 2022 (€ 505,184) Unfavourable step	€ 601,516 Total debts 2024: € 601,516 ▼ 2% vs 2023 (€ 615,807) Favourable step	€ 534,789 Total debts 2025: € 534,789 ▼ 11% vs 2024 (€ 601,516) Favourable step	▼ 11%
Cash	€ 144,727 Cash 2022: € 144,727 First fiscal year in the series	€ 156,232 Cash 2023: € 156,232 ▲ 8% vs 2022 (€ 144,727) Favourable step	€ 99,028 Cash 2024: € 99,028 ▼ 37% vs 2023 (€ 156,232) Unfavourable step	€ 81,535 Cash 2025: € 81,535 ▼ 18% vs 2024 (€ 99,028) Unfavourable step	▼ 18%
Land & buildings	€ 29,643 Land & buildings 2022: € 29,643 First fiscal year in the series	€ 26,557 Land & buildings 2023: € 26,557 ▼ 10% vs 2022 (€ 29,643) Unchanged	€ 25,282 Land & buildings 2024: € 25,282 ▼ 5% vs 2023 (€ 26,557) Unchanged	€ 22,007 Land & buildings 2025: € 22,007 ▼ 13% vs 2024 (€ 25,282) Unchanged	▼ 13%
Retained profit	€ 131,006 Retained profit 2022: € 131,006 First fiscal year in the series	€ 133,996 Retained profit 2023: € 133,996 ▲ 2% vs 2022 (€ 131,006) Favourable step	€ 137,417 Retained profit 2024: € 137,417 ▲ 3% vs 2023 (€ 133,996) Favourable step	€ 111,318 Retained profit 2025: € 111,318 ▼ 19% vs 2024 (€ 137,417) Unfavourable step	▼ 19%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 Unchanged (€ 100,000) Unchanged	€ 110,000 Dividend 2024: € 110,000 ▲ 10% vs 2023 (€ 100,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▼ 9% vs 2024 (€ 110,000) Unchanged	▼ 9%
Bank debt	€ 220,113 Bank debt 2022: € 220,113 First fiscal year in the series	€ 259,686 Bank debt 2023: € 259,686 ▲ 18% vs 2022 (€ 220,113) Unfavourable step	€ 225,222 Bank debt 2024: € 225,222 ▼ 13% vs 2023 (€ 259,686) Favourable step	€ 179,023 Bank debt 2025: € 179,023 ▼ 21% vs 2024 (€ 225,222) Favourable step	▼ 21%
Balance sheet total	€ 654,790 Balance sheet total 2022: € 654,790 First fiscal year in the series	€ 768,403 Balance sheet total 2023: € 768,403 ▲ 17% vs 2022 (€ 654,790) Unchanged	€ 757,533 Balance sheet total 2024: € 757,533 ▼ 1% vs 2023 (€ 768,403) Unchanged	€ 664,707 Balance sheet total 2025: € 664,707 ▼ 12% vs 2024 (€ 757,533) Unchanged	▼ 12%
Employees (FTE)	3.2 Employees (FTE) 2022: 3.2 First fiscal year in the series	3.2 Employees (FTE) 2023: 3.2 Unchanged (3.2) Unchanged	3.2 Employees (FTE) 2024: 3.2 Unchanged (3.2) Unchanged	3.2 Employees (FTE) 2025: 3.2 Unchanged (3.2) Unchanged

Key figures of Pharmacie CANIVET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie CANIVET?

What happened at Pharmacie CANIVET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 26, 2026 New annual accounts for financial year 2025: profit of € 73,901 (▼ 35% vs 2024). Source: NBB ↗
Mar 20, 1991 New establishment in Soignies. KBO
Feb 27, 1991 Start of the company according to the CBE. KBO

In short

From € 146,196 profit in 2022 to € 73,901 profit in 2025.

Paid € 144,390 in corporate taxes since 2022.

Best year ever: 2022, with € 146,196 profit.

On average € 103,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Alphar Naast

Pharmacie CANIVET

Behind Pharmacie CANIVET is Alphar Naast. The shares are held by Alphar Naast.

Directors

According to the 2025 annual accounts

Alphar Naast

Director · represented by Canivet Marie-Pascale

Also active at: Canivet Binche

Shareholders

Alphar Naast

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Place de Naast 27

7062 Soignies

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

PHARMACIE DE BATTIGNIES

€ 321,492 gross margin · 2025

Canivet Binche same network

€ 23,827 gross margin · 2025

ALPHAR NAAST same network

€ 180,711 gross margin · 2025

GROUPE PHARMACIE CANIVET

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0443.306.331

VAT number

BE 0443.306.331

Registered office

Place de Naast 27, 7062 Soignies

Names & denominations

Pharmacie CANIVET

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 February 1991

Peppol

Active · Active since 17 Jul 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie CANIVET

Financials

What happened to Pharmacie CANIVET?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions